High-density lipoprotein cholesterol as a predictor of coronary heart disease risk. The PROCAM experience and pathophysiological implications for reverse cholesterol transport-Reference-Cited by-同舟云学术

High-density lipoprotein cholesterol as a predictor of coronary heart disease risk. The PROCAM experience and pathophysiological implications for reverse cholesterol transport

Published:1996-07 Issue: Volume:124 Page:S11-S20
ISSN:0021-9150
Container-title:Atherosclerosis
language:en
Short-container-title:Atherosclerosis

Author:

Assmann Gerd,Schulte Helmut,von Eckardstein Arnold,Huang Yadong

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference35 articles.

1. NIH Consensus Development Panel on Triglyceride, High Density Lipoprotein, and Coronary Heart Disease, NIH Consensus Conference. Triglyceride, high-density lipoprotein and coronary heart disease,1993

2. Prediction and early diagnosis of coronary disease. Prospective epidemiologic study of industrial workers in Westphalia;Assmann;Internist,1980

3. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge;Friedewald;Clin Chem,1972

4. PROCAM Trial;Assmann,1986

5. Relation of high-density lipoprotein cholesterol and triglycerides to incidence of atherosclerotic coronary artery disease (the PROCAM experience). Prospective cardiovascular Munster study;Assmann;Am J Cardiol,1992

Cited by 586 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Special Patient Populations;Clinical Lipidology;2024

2. Obicetrapib: Reversing the Tide of CETP Inhibitor Disappointments;Current Atherosclerosis Reports;2023-12-22

3. Statins influence the relationship between ATP-binding cassette A1 membrane transporter-mediated cholesterol efflux capacity and coronary atherosclerosis in rheumatoid arthritis;Journal of Translational Autoimmunity;2023-12

4. A Nutraceutical Compound Containing a Low Dose of Monacolin K, Polymethoxyflavones, Phenolic Acids, Flavonoids, and Hydroxytyrosol Improves HDL Functionality;Current Vascular Pharmacology;2023-11

5. HDL functionality is dependent on hepatocyte stress defense factors Nrf1 and Nrf2;Frontiers in Physiology;2023-07-12